logo

Fennec Pharmaceuticals Inc (FENC)



Trade FENC now with
  Date
  Headline
9/21/2020 6:36:36 AM Fennec Reports Issuance Of U.S. Patent For PEDMARK
8/11/2020 6:11:51 AM Fennec Pharma Receives CRL From FDA For PEDMARK To Prevent Ototoxicity Associated With Cisplatin
6/26/2020 6:17:32 AM Fennec Pharma Announces Amendment To Increase Existing Senior Debt Facility With The Life Sciences Group To $18 Mln
5/14/2020 6:08:55 AM Fennec Q1 Net Loss $3.8 Mln Or $0.19/Shr
2/28/2020 6:08:00 AM Fennec Pharma Gets European Medicines Agency Validation For MAA For Sodium Thiosulfate
2/14/2020 6:09:12 AM Fennec Pharma Q4 Net Losses $3.6 Mln Or $0.18/Shr Vs $3.0 Mln Or $0.15/Shr Last Year
2/11/2020 6:09:12 AM Fennec Pharma Completes Rolling Submission Of NDA For PEDMARK; Submits MAA To European Medicines Agency
9/24/2019 6:05:42 AM Fennec Pharma Appoints Jodi Cook To Board
9/9/2019 6:20:42 AM Fennec Appoints Shubh Goel As Chief Commercial Officer
5/10/2019 8:39:36 AM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) FY19 Estimate To -0.61 From 2.74
5/10/2019 8:39:20 AM Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q4 19 Estimate To -0.17 From 3.37
5/10/2019 8:39:07 AM Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q3 19 Estimate To -0.16 From -0.23
5/10/2019 8:38:53 AM Wedbush Is Raising Fennec Pharmaceuticals Inc (FENC) Q2 19 Estimate To -0.15 From -0.21
5/10/2019 8:38:18 AM Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $16 Price Target
3/14/2019 7:44:51 AM Wedbush Reiterates Fennec Pharmaceuticals Inc (FENC) At Outperform With $16 Price Target